Citius Pharmaceuticals
CTXR
CTXR
6 hedge funds and large institutions have $2.17M invested in Citius Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
1
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$1.99M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$81K |
| 3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$43K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$17K |
Top Sellers
| 1 |
DCM
1
Delpha Capital Management
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $1.99M | 641,201 | +431,070 | +205% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $81K | 26,052 | +15,002 | +136% |
|
|
3
Dimensional Fund Advisors
Austin,
Texas
| $43K | 13,938 | +13,938 | New |
|
|
RJA
4
Raymond James & Associates
St Petersburg,
Florida
| $37K | 12,000 | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $17K | 5,545 | +4,040 | +268% |
|
|
HFM
6
Hartford Financial Management
Hartford,
Connecticut
| $1K | 500 | – | – |
|
|
DCM
7
Delpha Capital Management
New York
| – | – | -739 | Closed |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| – | – | – | – |
|